Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira Pastan

Showing results (1-10 of 340) with videos related to

Pageof 34
Sort By:
The Journal of Biological Chemistry|March 31, 2005
An NIH career: from bedside to basic research and backIra Pastan
Cancer Immunology, Immunotherapy : CII|April 18, 2003
Immunotoxins containing Pseudomonas exotoxin A: a short historyIra Pastan
Oncotarget|February 17, 2012
Modulating mesothelin shedding to improve therapyIra Pastan, Yujian Zhang
Cancer Research|May 15, 2014
Discovery of mesothelin and exploiting it as a target for immunotherapyIra Pastan, Raffit Hassan
Toxins|January 10, 2019
<i>Pseudomonas</i> Exotoxin Immunotoxins and Anti-Tumor Immunity: From Observations at the Patient's Bedside to Evaluation in Preclinical ModelsYasmin Leshem, Ira Pastan
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Mammalian cell display for antibody engineeringMitchell Ho, Ira Pastan
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2009
Display and selection of scFv antibodies on HEK-293T cellsMitchell Ho, Ira Pastan
Frontiers in Immunology|July 23, 2020
Immunogenicity of Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A: Causes, Consequences, and MitigationRonit Mazor, Ira Pastan
Advanced Drug Delivery Reviews|August 15, 2009
Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeuticsSatoshi Nagata, Ira Pastan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
High shed antigen levels within tumors: an additional barrier to immunoconjugate therapyYujian Zhang, Ira Pastan
Pageof 34

Showing results (1-10 of 340) with videos related to

Sort By:
Pageof 34
The Journal of Biological Chemistry|March 31, 2005
An NIH career: from bedside to basic research and backIra Pastan
Cancer Immunology, Immunotherapy : CII|April 18, 2003
Immunotoxins containing Pseudomonas exotoxin A: a short historyIra Pastan
Oncotarget|February 17, 2012
Modulating mesothelin shedding to improve therapyIra Pastan, Yujian Zhang
Cancer Research|May 15, 2014
Discovery of mesothelin and exploiting it as a target for immunotherapyIra Pastan, Raffit Hassan
Toxins|January 10, 2019
<i>Pseudomonas</i> Exotoxin Immunotoxins and Anti-Tumor Immunity: From Observations at the Patient's Bedside to Evaluation in Preclinical ModelsYasmin Leshem, Ira Pastan
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Mammalian cell display for antibody engineeringMitchell Ho, Ira Pastan
Methods in Molecular Biology (Clifton, N.J.)|June 26, 2009
Display and selection of scFv antibodies on HEK-293T cellsMitchell Ho, Ira Pastan
Frontiers in Immunology|July 23, 2020
Immunogenicity of Immunotoxins Containing <i>Pseudomonas</i> Exotoxin A: Causes, Consequences, and MitigationRonit Mazor, Ira Pastan
Advanced Drug Delivery Reviews|August 15, 2009
Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeuticsSatoshi Nagata, Ira Pastan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
High shed antigen levels within tumors: an additional barrier to immunoconjugate therapyYujian Zhang, Ira Pastan
Pageof 34